rs1558064

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002047.4(GARS1):​c.659-43C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.598 in 1,482,540 control chromosomes in the GnomAD database, including 277,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 21416 hom., cov: 32)
Exomes 𝑓: 0.61 ( 255973 hom. )

Consequence

GARS1
NM_002047.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.151

Publications

12 publications found
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 2D
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • neuronopathy, distal hereditary motor, type 5A
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
  • spinal muscular atrophy, infantile, James type
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-30603453-C-A is Benign according to our data. Variant chr7-30603453-C-A is described in ClinVar as [Benign]. Clinvar id is 258537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.642 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GARS1NM_002047.4 linkc.659-43C>A intron_variant Intron 5 of 16 ENST00000389266.8 NP_002038.2 P41250-1
GARS1NM_001316772.1 linkc.497-43C>A intron_variant Intron 5 of 16 NP_001303701.1 P41250-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GARS1ENST00000389266.8 linkc.659-43C>A intron_variant Intron 5 of 16 1 NM_002047.4 ENSP00000373918.3 P41250-1
GARS1ENST00000675651.1 linkc.659-43C>A intron_variant Intron 5 of 16 ENSP00000502513.1 A0A6Q8PGZ8
GARS1ENST00000675810.1 linkc.557-43C>A intron_variant Intron 4 of 15 ENSP00000502743.1 A0A6Q8PHH9
GARS1ENST00000675693.1 linkc.491-43C>A intron_variant Intron 6 of 17 ENSP00000502174.1 A0A6Q8PGA8
GARS1ENST00000675051.1 linkc.458-43C>A intron_variant Intron 5 of 16 ENSP00000502296.1 A0A6Q8PGI6
GARS1ENST00000674815.1 linkc.290-43C>A intron_variant Intron 5 of 16 ENSP00000502799.1 A0A6Q8PGW4
GARS1ENST00000674851.1 linkc.290-43C>A intron_variant Intron 6 of 17 ENSP00000502451.1 A0A6Q8PGW4
GARS1ENST00000444666.6 linkn.659-43C>A intron_variant Intron 5 of 17 3 ENSP00000415447.2 H7C443
GARS1ENST00000674616.1 linkn.*373-43C>A intron_variant Intron 6 of 17 ENSP00000502408.1 A0A6Q8PGT3
GARS1ENST00000674643.1 linkn.659-43C>A intron_variant Intron 5 of 16 ENSP00000501636.1 A0A6Q8PF45
GARS1ENST00000674737.1 linkn.659-43C>A intron_variant Intron 5 of 17 ENSP00000502464.1 A0A6Q8PGZ9
GARS1ENST00000674807.1 linkn.659-43C>A intron_variant Intron 5 of 15 ENSP00000502814.1 A0A6Q8PFZ6
GARS1ENST00000675529.1 linkn.*529-43C>A intron_variant Intron 6 of 17 ENSP00000501655.1 A0A6Q8PFN0
GARS1ENST00000675859.1 linkn.659-43C>A intron_variant Intron 5 of 14 ENSP00000502033.1 A0A6Q8PFZ6
GARS1ENST00000676088.1 linkn.*529-43C>A intron_variant Intron 6 of 18 ENSP00000501884.1 A0A6Q8PFN0
GARS1ENST00000676140.1 linkn.659-43C>A intron_variant Intron 5 of 16 ENSP00000502571.1 A0A6Q8PH49
GARS1ENST00000676164.1 linkn.*110-43C>A intron_variant Intron 5 of 16 ENSP00000501986.1 A0A6Q8PFV5
GARS1ENST00000676210.1 linkn.659-43C>A intron_variant Intron 5 of 17 ENSP00000502373.1 A0A6Q8PGN7
GARS1ENST00000676259.1 linkn.*91-43C>A intron_variant Intron 5 of 16 ENSP00000501980.1 A0A6Q8PFU7
GARS1ENST00000676403.1 linkn.659-43C>A intron_variant Intron 5 of 15 ENSP00000502681.1 A0A6Q8PHI7

Frequencies

GnomAD3 genomes
AF:
0.483
AC:
73395
AN:
151924
Hom.:
21419
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.606
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.419
Gnomad FIN
AF:
0.644
Gnomad MID
AF:
0.560
Gnomad NFE
AF:
0.647
Gnomad OTH
AF:
0.514
GnomAD2 exomes
AF:
0.559
AC:
138079
AN:
246982
AF XY:
0.561
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.557
Gnomad ASJ exome
AF:
0.666
Gnomad EAS exome
AF:
0.488
Gnomad FIN exome
AF:
0.638
Gnomad NFE exome
AF:
0.643
Gnomad OTH exome
AF:
0.589
GnomAD4 exome
AF:
0.611
AC:
812985
AN:
1330496
Hom.:
255973
Cov.:
20
AF XY:
0.606
AC XY:
405808
AN XY:
669240
show subpopulations
African (AFR)
AF:
0.119
AC:
3671
AN:
30766
American (AMR)
AF:
0.552
AC:
24482
AN:
44374
Ashkenazi Jewish (ASJ)
AF:
0.669
AC:
16949
AN:
25350
East Asian (EAS)
AF:
0.451
AC:
17605
AN:
39050
South Asian (SAS)
AF:
0.422
AC:
35202
AN:
83482
European-Finnish (FIN)
AF:
0.638
AC:
33822
AN:
53048
Middle Eastern (MID)
AF:
0.557
AC:
2413
AN:
4336
European-Non Finnish (NFE)
AF:
0.650
AC:
646487
AN:
994172
Other (OTH)
AF:
0.579
AC:
32354
AN:
55918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
15788
31576
47365
63153
78941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15962
31924
47886
63848
79810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.483
AC:
73392
AN:
152044
Hom.:
21416
Cov.:
32
AF XY:
0.481
AC XY:
35713
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.141
AC:
5837
AN:
41504
American (AMR)
AF:
0.534
AC:
8148
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2369
AN:
3470
East Asian (EAS)
AF:
0.476
AC:
2457
AN:
5160
South Asian (SAS)
AF:
0.421
AC:
2028
AN:
4820
European-Finnish (FIN)
AF:
0.644
AC:
6797
AN:
10562
Middle Eastern (MID)
AF:
0.554
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
0.647
AC:
43962
AN:
67942
Other (OTH)
AF:
0.512
AC:
1081
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1567
3133
4700
6266
7833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.510
Hom.:
3368
Bravo
AF:
0.460

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinal muscular atrophy, infantile, James type Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 2D Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuronopathy, distal hereditary motor, type 5A Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.1
DANN
Benign
0.53
PhyloP100
-0.15
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1558064; hg19: chr7-30643069; COSMIC: COSV66828323; COSMIC: COSV66828323; API